July 27, 2024Pharmaceutical BiologyOpen Access

Study of the multitarget mechanism of Astragalus (HUANGQI) in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking technology

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Network pharmacology analysis explores multitarget mechanisms of astragalus in Alzheimer disease, highlighting potential therapeutic pathways.

Huangqi targets multiple biological pathways in Alzheimer's disease treatment, though a comprehensive understanding of its protective mechanisms remains currently incomplete.
Network pharmacology and molecular docking technology evaluate the multitarget mechanism of astragalus, providing a computational framework for therapeutic assessment.
Supports characterization of traditional herbal interventions for Alzheimer's disease, but clinical applications require further experimental and molecular validation.

Lv et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Network pharmacology analysis explores multitarget mechanisms of astragalus in Alzheimer disease, highlighting potential therapeutic pathways.